Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dieter Lemke
Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
Clinical Cancer Research
Cancer Research
Oncology
Herg K+ Channel-Dependent Apoptosis and Cell Cycle Arrest in Human Glioblastoma Cells
PLoS ONE
Multidisciplinary
Related publications
Trametinib: A MEK Inhibitor for Management of Metastatic Melanoma
OncoTargets and Therapy
Oncology
Pharmacology
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Shipping Out MEK Inhibitor Resistance With SHP2 Inhibitors
Cancer Discovery
Oncology
Cellular Quiescence Caused by the Mdm2 Inhibitor Nutlin-3a
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
U0126 Protects Cells Against Oxidative Stress Independent of Its Function as a MEK Inhibitor
ACS Chemical Neuroscience
Biochemistry
Medicine
Physiology
Cell Biology
Cognitive Neuroscience
P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53
Oncogene
Cancer Research
Genetics
Molecular Biology
The Physiological mTOR Complex 1 Inhibitor DDIT4 Mediates Therapy Resistance in Glioblastoma
British Journal of Cancer
Cancer Research
Oncology
Trametinib Modulates Cancer Multidrug Resistance by Targeting ABCB1 Transporter
Oncotarget
Oncology
PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells
Cancer Research
Cancer Research
Oncology